Robert Jan Galema - 08 Jun 2022 Form 4 Insider Report for Shapeways Holdings, Inc. (SHPW)

Role: Director
Signature: /s/ Jennifer Walsh, Attorney-in-Fact
Issuer symbol: SHPW
Transactions as of: 08 Jun 2022
Transactions value $: $0
Form type: 4
Date filed: 10 Jun 2022, 08:28
Previous filing: 01 Oct 2021
Next filing: 20 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SHPW	Common Stock	Award	$0	+31.3K		$0.00	31.3K	08 Jun 2022	Direct	F1
holding	SHPW	Common Stock						3.51M	08 Jun 2022	Held by Stichting Depositary INKEF Investment Fund	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the one-year anniversary of June 8, 2022, subject to the Reporting Person's continuous service with the issuer through such date.
F2	Robert John Galema, Roel Bulthuis, Corne Jansen and Wolfgang Noldeke together exercise voting and investment control over shares held by Stichting Depositary INKEF Investment Fund.

Content

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the one-year anniversary of June 8, 2022, subject to the Reporting Person's continuous service with the issuer through such date.

Robert John Galema, Roel Bulthuis, Corne Jansen and Wolfgang Noldeke together exercise voting and investment control over shares held by Stichting Depositary INKEF Investment Fund.